ScreenerHero

AELIS Aelis Farma SA

EPA · FR · Healthcare · Biotechnology · aelisfarma.com
0.8380EUR-4.23%Mkt Cap: 12.42M $P/E: —

Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company owns a pipeline of pharmacolo…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap12.42M USD
Enterprise Value10.60M USD
Revenue (TTM)2.38M USD
Gross Profit3.89M USD
Net Income (TTM)-6.99M USD
Revenue/Share0.16 EUR
Last Price0.8380 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees14
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0014007ZB4
Valuation
P/E (Trailing)—
P/E (Forward)5.15
PEG—
EV/EBITDA-2.21
EV/Revenue4.45
P/S5.44
P/B2.68
EPS (TTM)-0.33
EPS (Forward)0.17
52W Range
0.83001% of range2.300
52W High2.300 EUR
52W Low0.8300 EUR
Profitability
Gross Margin163.46%
Oper. Margin-601.56%
EBITDA Margin-200.87%
Profit Margin-216.29%
ROE-144.94%
ROA-53.40%
Growth
Revenue Growth31.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.82M USD
CapEx (TTM)4.35K USD
FCF Margin-68.69%
FCF Yield-13.18%
Net Debt-2.44M USD
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity1.49
Current Ratio9.80
Quick Ratio9.48
Book Value/Sh0.33 EUR
Cash/Share0.48 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.63M
Float4.07M
Insiders36.44%
Institutions27.38%
Technical
SMA 500.9927 (-15.6%)
SMA 2001.178 (-28.9%)
Beta0.62
S&P 52W Chg14.58%
Avg Vol (30d)13.46K
Avg Vol (10d)8.39K
Technical Indicators
RSI (14)28.4
MACD-0.0363
MACD Signal-0.0331
MACD Hist.-0.0032
BB Upper1.026 EUR
BB Middle0.9231 EUR
BB Lower0.8201 EUR
BB Width22.30%
ATR (14)0.0338 EUR
Vol Ratio (20d)0.68x